Overview

Special Drug Use Investigation for VALTREX (Valaciclovir) (Suppression Prophylaxis)

Status:
Completed
Trial end date:
2011-03-01
Target enrollment:
0
Participant gender:
All
Summary
The purpose of this study is to collect and assess information on proper use of valaciclovir regarding safety and efficacy of long-term use in suppressive therapy for subjects with recurrent genital herpes.
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
GlaxoSmithKline
Treatments:
Acyclovir
Valacyclovir
Criteria
Inclusion Criteria:

- Subjects who started suppressive therapy for recurrent genital herpes for the first
time

Exclusion Criteria:

- Subjects with a history of hypersensitivity to the ingredients of VALTREX or aciclovir